FDA
-
-
-
-
-
-
-
FSD Pharma Appoints Larry Kaiser, MD, FACS, Dean, Lewis Katz School of Medicine at Temple University as Chairman of Its Scientific Advisory Board
-
-
-
-
-
-
-
FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a NASDAQ Traded Pharmaceutical Company Focusing on the Development of Cannabinoid-Based Treatments, to Create Medical Cannabis Industry In
322,943 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

